Trial Profile
Empirical Versus Pre-emptive (Diagnostic-driven) Antifungal Therapy of Patients Treated for Haematological Malignancies or Receiving an Allogeneic Stem Cell Transplant. A Therapeutic Open Label Phase III Strategy Study of the EORTC Infectious Diseases and Leukemia Groups
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Dec 2023
Price :
$35
*
At a glance
- Drugs Caspofungin (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- 07 Aug 2019 Status changed from active, no longer recruiting to completed.
- 12 Jul 2019 This trial has been completed in Slovakia, according to European Clinical Trials Database.
- 10 Jul 2019 This trial has been completed in Germany, according to European Clinical Trials Database.